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Abstract: Freeze-dried poly(D,L-lactic acid) macroporous scaffold filled with a fibrin 
solution containing Schwann cells (SCs) lentivirally transduced to produce and secrete D15A, 
a bi-functional neurotrophin with brain-derived neurotrophic factor and neurotrophin-3 
activity, and to express green fluorescent protein (GFP) were implanted in the completely 
transected adult rat thoracic spinal cord. Control rats were similarly injured and then 
implanted with scaffolds containing the fibrin solution with SCs lentivirally transduced to 
produce express GFP only or with the fibrin solution only. Transgene production and 
biological activity in vitro, SC survival within the scaffold in vitro and in vivo, scaffold 
integration, axonal regeneration and myelination, and hind limb motor function were analyzed 
at 1, 2, and 6 weeks after implantation. In vitro, lentivirally transduced SCs produced 87.5 
ng/24h/10
6
 cells of D15A as measured by neurotrophin-3 activity in ELISA. The secreted 
D15A was biologically active as evidenced by its promotion of neurite outgrowth of dorsal 
root ganglion neurons in culture. In vitro, SCs expressing GFP were present in the scaffolds 
for up to 6 h, the end of a typical surgery session. Implantation of SC-seeded scaffolds caused 
modest loss of spinal nervous tissue. Reactive astrocytes and chondroitin sulfate 
glycosaminoglycans were present in spinal tissue adjacent to the scaffold. Vascularization of 
the scaffold was ongoing at 1 week post-implantation. There were no apparent differences in 
scaffold integration and blood vessel formation between groups. A decreasing number of 
implanted (GFP-positive) SCs were found within the scaffold during the first 3 days after 
implantation. Apoptosis was identified as one of the mechanisms of cell death. At 1 week and 
later time points after implantation, few of the implanted SCs were present in the scaffold. 
Neurofilament-positive axons were found in the scaffold. At 6 weeks post-grafting, 
myelinated axons were observed within and at the external surface of the scaffold. Axons did 
not grow from the scaffold into the caudal cord. All groups demonstrated a similar 
improvement of hind limb motor function. Our findings demonstrated that few seeded SCs 
survived in vivo, which could account for the modest axonal regeneration response into and 
across the scaffold. For the development of SC-seeded macroporous scaffolds that effectively 
promote axonal regeneration in the injured spinal cord, the survival and/or total number of 
SCs in the scaffold needs to be improved.  
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1. Introduction 
 
Injury to the adult mammalian spinal cord elicits a cascade of pathophysiological events that 
results in loss of nervous tissue, and, consequently, in partial or complete loss of neurological 
functions. For restoration of locomotor function following an injury, damaged axons need to 
regenerate across and beyond the injury site and form synaptic connections with neurons 
involved in motor function. Implantation of cells within the injured area may provide the 
regenerating axons with a substrate that will promote and support axonal growth towards the 
denervated neurons. 
The efficacy of Schwann cells (SCs) to promote axonal regeneration and myelination in the 
injured adult rat spinal cord has been demonstrated repeatedly [1-4]. Following a complete 
transection and removal of several millimeters of the spinal cord, grafting a non-degradable 
polyacrylnitril/polyvinylchloride (PAN/ PVC) tubular scaffold filled with SCs that bridged 
both cord stumps, which were placed within the scaffold, resulted in axonal regeneration and 
myelination [1,3-5]. The use of a tubular scaffold for cell implantation in the injured cord may 
be beneficial to the overall axonal growth process by preventing scar formation, allowing 
accumulation of growth-promoting molecules, and serving as a protective casing for the 
implant. On the other hand, it can be anticipated that a non-degradable tubular scaffold 
becomes harmful during the later stages of the growth/recovery response by constricting the 
spinal cord and/or eliciting a foreign body response. The use of biodegradable scaffolds to 
implant axonal growth-promoting substrates may circumvent these potential problems. 
A widely used biodegradable material in tissue engineering is poly(D,L-lactic acid) (PLA). In 
vivo and in vitro, PLA and its breakdown products were demonstrated to be biocompatible 
with spinal cord tissue and with SCs [6]. Implantation of a PLA single-channel tubular 
scaffold containing SC into the completely transected adult rat spinal cord resulted at first in 
an axonal regeneration response comparable to that seen with a SC-filled non-degradable 
PAN/PVC channel [7]. However, in time axonal growth was obstructed due to the collapse of 
the PLA scaffold. Recently, Patist et al. [8] demonstrated that the implantation of a 
macroporous PLA tubular scaffold in the transected rat spinal cord elicited a modest axonal 
regeneration response. These particular scaffolds were prepared by a thermally induced 
polymer-solvent phase separation process and contained longitudinally oriented macropores 
connected to each other by a network of micropores [8]. It was proposed that seeding these 
scaffolds with SCs prior to implantation would be beneficial for the overall axonal growth 
response [8]. 
Here, we have filled a freeze-dried PLA macroporous guidance scaffold with genetically 
modified rat SCs and analyzed cell survival, scaffold integration, and the axonal regeneration 
response following implantation into the completely transected adult rat thoracic spinal cord. 
Control rats were implanted with scaffolds filled with a fibrin solution with or without SCs 
genetically modified to express green fluorescent protein (GFP) for easy and reliable 
identification of the SCs. Experimental rats were grafted with scaffolds with the fibrin 
solution with SCs genetically modified to express GFP and, in addition, to produce and 
secrete a bi-functional neurotrophin (D15A), a molecule with brain-derived neurotrophic 
factor (BDNF) and neurotrophin-3 (NT-3) activity [9], to evaluate the effects of elevated 
levels of neurotrophins within the graft environment [3,10]. 
 
2. Materials and methods 
 
2.1.   Animals 
 
Female Fischer rats (n = 37, 160-180g; Charles River Laboratories, Wilmington, NC) were 
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housed according to NIH and USDA guidelines. The Institutional Animal Care and Use 
Committee of the University of Miami approved all animal procedures. Rats were 
anesthetized using a mixture of ketamine (42.8mg/ml), xylazine (98.6mg/ml) and aceproma-
zine (1.4mg/ml) at 0.06ml/100 g body weight, intramuscularly. The backs were shaved and 
aseptically prepared. Lacrilube ophthalmic ointment (Allergen Pharmaceuticals, Irvine, CA) 
was applied to the eyes to prevent drying and gentamicin (0.03 ml, Buck, Inc., Owings Mills, 
MO) was given intramuscularly. During surgery the rats were kept on a heating pad to 
maintain the body temperature at 37 ± 0.5°C. 
 
2.2.   Purification of Schwann cells 
 
Highly purified SC cultures were obtained from sciatic nerves of adult female Fischer rats 
(Charles River Laboratories) as described previously [11]. Dissociated SCs were cultured on 
poly-L-lysine-coated tissue culture dishes in DF-10S medium supplemented with the 
mitogens, bovine pituitary extract (2mg/ml), forskolin (0.8g/ml), and heregulin (2.5nM). The 
addition of heregulin is a modification of the original protocol. To determine the purity of the 
SCs used for seeding the polymer scaffolds, samples of the harvested cells were plated onto 
culture dishes, cultured for 3h, stained for S100, and then coverslipped with Citifluor (UKC 
Chemical Laboratory, Canterbury, England) with 100 mM Hoechst nuclear dye (Sigma, St. 
Louis, MO) to compare numbers of S100-positive cells with Hoechst-labeled cells. The purity 
of the SCs used for seeding the scaffolds was 95-98%. 
 
2.3.   Preparation of lentiviral vectors and transduction of SCs 
 
The ViraPower Lentiviral Expression System (Invitrogen) was used to generate lentiviral 
vectors (LVs) encoding only GFP or both D15A and GFP. Briefly, cDNA of GFP (Clontech) 
and D15A (kind gift of Dr. Pantelis Tsoulfas, The Miami Project to Cure Paralysis) was 
amplified by PCR and subcloned into an expression/packaging plasmid. Expression was 
under control of the human cytomegalovirus promotor and the Woodchuck hepatitis virus 
Post-transcrip-tional Regulatory Element. Next, 293 T cells were co-transfected with the 
expression/packaging plasmid and three helper plasmids (pLP1, pLP2, and pLP/VSVG) and 
then cultured in DMEM supplemented with 10% fetal bovine serum and gentamycin 
(Invitrogen). The medium of trans-fected 293 T cells, which contained the LVs, was collected 
and used to transduce SCs ex vivo at passage 2 at a multiplicity of infection of 30. Routinely, 
a transduction rate of >95% was achieved with LV-GFP. The transduced SCs were further 
cultured until passage 4 and then collected for seeding into the polymer scaffolds (see below). 
We used conditioned medium from these cultures to determine the amount of the secreted 
D15A molecule. The D15A molecule has an active NT-3 backbone with BDNF activity as 
well [9]. To determine the amount of secreted D15A, NT-3 levels were measured using 
ELISA according to manufacturer's instructions (Promega). The biological activity of the 
D15A molecule present in the medium of the cultures of transduced SCs was confirmed using 
a bioassay measuring neurite outgrowth from dorsal root ganglia (DRG; [12,13]). Rat embryo 
DRGs were aseptically removed, pooled in ice-cold L-15 Leibovitz medium with  
L-glutamine (Gibco BRL), and then placed in 50 ml DMEM/10% fetal calf serum onto glass 
coverslips coated with poly-L-ornithine (500mg/ml in 0.1-M boric acid, pH 8.3) and laminin 
(10mg/ml; Roche, Basel, Switzerland). The glass coverslips were placed in a 6-well plate (n = 
3 per well) and kept overnight in an incubator at 37 °C, 5% CO2. Next, the DRG were 
immersed for 24 h in conditioned medium. This medium was then refreshed and the cultures 
were grown for an additional 48 h at 37 °C, 5% CO2. The cultures were fixed in 4% 
paraformaldehyde in phosphate buffer (PB; 0.1 M, pH 7.4) for 2h and subsequently stained 
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with anti-neurofilament antibodies to visualize the neurites. 
 
2.4. Preparation of the poly(D,L-lactic acid) macroporous tubular scaffolds 
 
One gram of PLA (Resomer® R-206; Mn: 50,000, Boehringer-Ingelheim, Germany) and 50 
mg of poly(D,L-lactide-b-ethylene oxide) 4k-4k copolymer (Mn: 10,000, CERM, Liege, 
Belgium) were dissolved in 10 ml dimethylcar-bonate (DMC, Acros) and filtered over 0.45 
mm. Five milliliter of this polymer solution within a 50 ml-round bottom flask was then 
frozen with liquid nitrogen and freeze-dried by vacuum sublimation for 72 h at — 10°C, for 
5h at 0°C, and finally at room temperature until it reached a constant weight. The fabrication 
and the in vitro degradation characteristics of the polymer scaffolds were described previously 
[8,14,15]. Using a metal trephine with an inner diameter of 2.6mm, 1cm long rods were cut 
from the polymer foam following the longitudinal direction of the pores. The rods were 
sterilized by UV exposure under a laminar flow for 15min. These sterilized rods were kept at -
80°C until use. Just before surgery, the rods were thawed, cut into 4 mm long segments, 
seeded with SCs (see below) and kept in L15 medium with 1% fibrinogen (Sigma) and 0.1% 
gentamicin (Buck, Inc.) until grafting. As shown in Fig. 1a and b, the scaffolds have 
longitudinal orientated macropores connected by micropores (diameter < 10 µm). The 
diameter of the macropores varied between 75 and 200 µm [8]. 
 
2.5.   Seeding and survival of SCs into the macroporous tubular scaffolds 
 
Scaffolds were first filled with a 1% fibrinogen (Type 1, human plasma; Sigma) in DMEM 
with 2% CaCl2, 0.2% gentamicin (Sigma), and 2% aprotinin (Sigma). This fibrin mixture was 
drawn into scaffolds using a Vacutainer (Becton-Dickinson, Franklin Lakes, NJ). Then, 1 x 
10
6
 SCs in 5 ml fibrin mixture was placed on the top of the scaffold, which was drawn gently 
inside by placing the scaffold onto Whatman filter paper (# 1). The cells were generally 
uniformly distributed within the pores of the scaffold although some small clusters of cells 
could also be discerned (Fig. 1c and d). The SC-seeded scaffold was placed into a tissue 
culture dish with L15 medium with 1% fibrinogen (Sigma) and 0.1% gentamicin (Buck, Inc.) 
until implantation. In vitro, SC survival was studied up to 6h after seeding. In vivo, SCs 
survival was evaluated by investigating the presence of GFP-positive cells within the scaffold 
at 1 and 3 days and at 1, 2, and 6 weeks after implantation into the transected spinal cord. The 
presence of apoptotic SCs within the scaffold was investigated at the same time points using 
immunostaining (see below) for active caspase-3, a marker for apoptotic cell death [16]. 
 
2.6.   Implantation of the SC-seeded scaffolds 
 
After opening the skin and muscle layers, a laminectomy was performed at the T8-9 vertebral 
level and the dura mater carefully opened. The exposed T9-10 spinal cord was transected and 
3 mm of tissue including visible spinal roots completely removed. After hemostasis was 
achieved, a 4 mm long scaffold with GFP-SCs or D 15A-GFP-SCs or the 1% fibrin solution 
alone was implanted in between the rostral and caudal spinal cord stumps. A layer of silicone 
sheeting (0.005'' thick) was placed on top of the implant and both cord stumps. The muscle 
layers were closed separately and the skin closed with metal wound clips. The rats received 
10 ml Ringers' solution subcutaneously and were placed in warmed cages with food and water 
readily available. To prevent urinary tract infection, gentamicin was administered daily during 
the first 7 days post-surgery. The bladders were expressed manually two times a day until 
voluntary bladder release returned. In case urinary tract infection occurred, gentamicin 
administration was reinitiated for 7 days. In total, 13 rats received a GFP-SC implant (n = 2 
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for 1 week, n = 5 for 2 weeks, n = 6 for 6 weeks); 13 rats received a D15A-GFP-SC implant 
(n = 2 for 1 week, n = 5 for 2 weeks, n = 6 for 6 weeks); seven rats received a fibrin only 
implant (n = 2 for 1 week, n = 2 for 2 weeks, n = 3 for 6 weeks). Also, two rats received a 
SC-seeded scaffold for 1 day and 2 rats for 3 days to assess short-term cell survival. Panels 1e 
and 1f show the scaffold in vivo after 1 and 6 weeks, respectively. 
 
 
Fig. 1. Macroporous poly (D,L-lactic acid) scaffolds can serve as vehicle for SC implantation. 
Scanning electron microscope photographs demonstrating a longitudinal section (a) and 
cross section (b) of the scaffold. Horizontal cryostat sections counterstained with DAPI 
revealed that GFP-positive SCs were present within scaffold 1 h (c) and 6h (d) after seeding. 
The lower panels show a dorsal view of the scaffold in vivo at 1 (e) and 6 (f) weeks after 
implantation. Scale bar in (a) represents 500 µm for panel (a) and 100 µm for panel (b-d). In 
panels (e) and (f) the distance between the scale bars is 1mm. 
 
2.7.   Assessment of hind limb motor function 
 
In rats that survived for 6 weeks, changes in hind limb function were assessed using the test 
developed by Basso, Beattie, and Bresnahan (BBB test; [17,18]), an open field test with a 21-
point scale (21 is normal). The ;BBB test distinguishes between movements of individual 
